Lonza has scored a contract manufacturing agreement from Osiris
Therapeutics for its investigational adult stem cell therapy is
building a new facility to support future business activities in
Invitrogen has announced the creation of a new business unit that
aims to further integrate its presence within the cell therapy
market, as it aims to stamp its authority specifically in the cell
analysis tools market.
Cambrex has initiated a project aimed at constructing a new
facility to accommodate four cGMP-compliant suites dedicated to
cell therapy manufacturing. The company said the expansion would
increase its manufacturing capacity by 100...